InvestorsHub Logo
Followers 1
Posts 1208
Boards Moderated 0
Alias Born 04/09/2005

Re: frogdreaming post# 27258

Monday, 06/06/2005 1:21:17 PM

Monday, June 06, 2005 1:21:17 PM

Post# of 82595
FROG Lets look Back...

You said;...

Gabriel has specifically stated that Ovanome does not yet meet DNAP standards and is not yet ready for the FDA. That means, in no uncertain terms, that the product does not yet meet it's own design requirements.

If 95% is the design goal, perhaps they can't meet that level of accuracy, or perhaps they can meet it but not in a reliable and repeatable manner. Whatever the obstacle, the company has clearly stated it's status. It does not yet meet it's requirements and therefore is not ready for the FDA.

Sooooo FROG....

Lets be VERY CLEAR HERE...

They have a product that has a 96% success rate....

They, with the help of Moffit are under going a clinical study as we speak....

We can expect results and issuance to the FDA in or around 6 to 9 months....

DNAP's ONLY obstacle to date was the $1,000 per patient....

To perform the OVA test....

It seems that this obstacle has been overcome.....

They are ready....

VERY VERY READY---GEO